The Impact of Osseodensification and Conventional Drilling Protocols on Implants Mechanical and Biological Stability in Posterior Maxilla: A Randomized Controlled Clinical Trial

Arab American University (Palestine)1 site in 1 country40 target enrollmentApril 4, 2022

ConditionsImplant Therapy

Overview

Phase: N/A
Intervention: Not specified
Conditions: Implant Therapy
Sponsor: Arab American University (Palestine)
Enrollment: 40
Locations: 1
Primary Endpoint: Mechanical or primary stability
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A total of 80 implants were placed in the posterior region of the maxilla in 40 patients in a split-mouth design. Bone quality was classified into type I, II, III, IV, or V as assessed preoperatively on cone-beam computed tomography (CBCT) . Primary implant stability was measured with insertion torque and resonance frequency analysis (ISQ values). Secondary stability was measured by ISQ at abutment installation.

Registry

clinicaltrials.gov

Start Date

April 4, 2022

End Date

February 1, 2023

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Arab American University (Palestine)

Responsible Party

Principal Investigator

Mahmoud Abu-Ta'a

Associate Professor

Arab American University (Palestine)

Eligibility Criteria

Inclusion Criteria

•(a) Bilateral edentulism in the maxillary posterior region dating back more than 6 months,
•(b) sufficient bone height (distance between the bone crest and maxillary sinus \>8 mm) and width at the alveolar crest (≥6 mm) that would not necessitate bone augmentation,
•(c) at least 2 mm vestibular keratinized mucosa width and 3 mm mucosa thickness,
•(d) full-mouth plaque and bleeding scores \<20%.

Exclusion Criteria

•patients with systemic diseases, conditions, or used medications having the potential to impair surgery, bone, and wound healing dynamics (such as diabetes) will be excluded.
•patients who are allergic to antibiotics and non-steroidal anti-inflammatory drugs
•bone height \<8mm
•ridge and soft tissue deficiencies requiring augmentation procedures and
•endodontic or periodontal lesions neighboring the edentulous sites will be also excluded.